文献速递脑血管病

睡眠呼吸障碍合并心房颤动对缺血性卒中后长期结局的影响

Impact of Comorbid Sleep-Disordered Breathing and Atrial Fibrillation on the Long-Term Outcome After Ischemic Stroke.
PubMed 文献 · Stroke · 2024-01-26

这项前瞻性队列研究纳入353例急性缺血性卒中或短暂性脑缺血发作患者,在急性住院期间筛查睡眠呼吸障碍,并在6个月内进行心房颤动筛查,随访至36个月。结果显示,合并中度至重度睡眠呼吸障碍与心房颤动的患者,后续死亡或脑心血管事件风险显著高于仅有中度至重度睡眠呼吸障碍者及两者均无者。

要点

  • 合并中度至重度睡眠呼吸障碍与心房颤动患者后续死亡或脑心血管事件风险升高。
  • 该风险高于仅有中度至重度睡眠呼吸障碍者(HR 2.49,95%CI 1.18-5.24)。
  • 该风险也高于两者均无者(HR 2.25,95%CI 1.12-4.50)。

核心结论

  • 合并中度至重度睡眠呼吸障碍与心房颤动显著增加急性缺血性卒中后长期死亡或复发性脑心血管事件的风险。
  • 作者认为,将这两种情况视为累积且可干预的脑心血管危险因素对急性卒中管理有意义。

研究设计与样本

  • 前瞻性队列研究,分析353例急性缺血性卒中或短暂性脑缺血发作患者。
  • 急性住院期间通过呼吸多导描记筛查睡眠呼吸障碍,前6个月内通过7天心电图筛查心房颤动,最多3次。
  • 随访访视安排于卒中后1、3、12、24、36个月。
  • 采用Cox回归模型评估合并睡眠呼吸障碍与心房颤动对后续死亡或脑心血管事件的影响,校正年龄、性别、体重指数、高血压、糖尿病、血脂异常和心力衰竭。

主要发现

  • 353例患者中,缺血性卒中299例,短暂性脑缺血发作54例;中位年龄67岁(四分位距57-74),男性占63%。
  • 中度至重度睡眠呼吸障碍(呼吸暂停低通气指数≥15/h)见于118例(33.4%)患者。
  • 心房颤动患者56例(15.9%),其中28例合并中度至重度睡眠呼吸障碍与心房颤动。
  • 36个月随访期间,死亡12例,复发性脑心血管事件67例。
  • 合并中度至重度睡眠呼吸障碍与心房颤动患者后续死亡或脑心血管事件风险高于仅有中度至重度睡眠呼吸障碍无心房颤动者(HR 2.49,95%CI 1.18-5.24),也高于无中度至重度睡眠呼吸障碍或心房颤动者(HR 2.25,95%CI 1.12-4.50);但与仅有心房颤动无中度至重度睡眠呼吸障碍者相比无显著差异(HR 1.64,95%CI 0.62-4.36)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sleep-disordered breathing (SDB) and atrial fibrillation (AF) are highly prevalent in patients with stroke and are recognized as independent risk factors for stroke. Little is known about the impact of comorbid SDB and AF on long-term outcomes after stroke. METHODS: In this prospective cohort study, 353 patients with acute ischemic stroke or transient ischemic attacks were analyzed. Patients were screened for SDB by respiratory polygraphy during acute hospitalization. Screening for AF was performed using a 7-day ECG up to 3× in the first 6 months. Follow-up visits were scheduled at 1, 3, 12, 24, and 36 months poststroke. Cox regression models adjusted for various factors (age, sex, body mass index, hypertension, diabetes, dyslipidemia, and heart failure) were used to assess the impact of comorbid SDB and AF on subsequent death or cerebro-cardiovascular events. RESULTS: Among 353 patients (299 ischemic stroke and 54 transient ischemic attacks), median age, 67 (interquartile range, 57-74) years with 63% males. Moderate-to-severe SDB (apnea-hypopnea index score, ≥15/h) was present in 118 (33.4%) patients. Among the 56 (15.9%) patients with AF, 28 had comorbid moderate-to-severe SDB and AF. Over 36 months, there were 12 deaths and 67 recurrent cerebro-cardiovascular events. Patients with comorbid moderate-to-severe SDB and AF had a higher risk of subsequent death or cerebro-cardiovascular events compared with those with only moderate-to-severe SDB without AF (hazard ratio, 2.49 [95% CI, 1.18-5.24]) and to those without moderate-to-severe SDB or AF (hazard ratio, 2.25 [95% CI, 1.12-4.50]). However, no significant difference was found between the comorbid moderate-to-severe SDB and AF group and the group with only AF without moderate-to-severe SDB (hazard ratio, 1.64 [95% CI, 0.62-4.36]). CONCLUSIONS: Comorbid moderate-to-severe SDB and AF significantly increase the risk of long-term mortality or recurrent cerebro-cardiovascular events after acute ischemic stroke. Considering both conditions as cumulative and modifiable cerebro-cardiovascular risk factors is of interest for the management of acute stroke. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02559739.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yang X, Lippert J, Dekkers M, et al. Impact of Comorbid Sleep-Disordered Breathing and Atrial Fibrillation on the Long-Term Outcome After Ischemic Stroke. Stroke. 2024. PMID: 38275115. doi:10.1161/STROKEAHA.123.042856

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。